share_log

Evelo Biosciences | EFFECT: Others

SEC announcement ·  Mar 11 06:06
Summary by Moomoo AI
The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.
The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more